Open Therapeutics and IPwe form intellectual property

Open Therapoid.net from Therapeutics

Through a partnership to improve IP licensing, the companies will work to jointly encourage the licensing of IP portfolios

Cincinnati, OH, and Paris, France – September 14, 2022 – Open Therapeutics, an open science company, and IPwe, a global platform leveraging the power of artificial intelligence, predictive analytics and blockchain technology around intelligent management of intangible assets, announce their collaboration to jointly advance the licensing of intellectual property.

Open Therapeutics’ mission is to enable the global research community to have a positive impact on human, animal, plant, and global environmental health. Its blockchain-based open science and open-access platform Therapoid.net is provided free of charge to the public, researchers and students. The Therapoid ecosystem provides grants, intellectual property, discussion forums, manuscript review tools, lab equipment, and ScienceCoins cryptocurrency prizes when students and scientists collaborate.

IPwe’s mission is to promote and encourage innovation with cutting-edge technology based on proven methods so that business leaders can better manage intangible assets. As a result, the IPwe team has an outstanding reputation in patent monetization due to their combined decades of experience. IPwe’s technology and expert team have discovered that many Open Therapeutics customer patents have potential for patent monetization and provide Open Therapeutics customers with access to IPwe’s artificial intelligence and to blockchain-based products to drive innovation.

IPwe Chief Innovation Officer Harry Stacpoole said, “Over 80% of Open Therapeutics customer patents are currently unlicensed despite potential patent monetization opportunities. Through our partnership with Open Therapeutics, we are able to offer their member companies, governments, academics and research institutions the opportunity to license their unused patents while pursuing our own mission of encouraging innovation by providing them with a mechanism to do it “.

According to Open Therapeutics Founder, Jason E. Barkeloo, “I am proud to work with IPwe to improve the value of intellectual property assets by increasing transparency with clear and verifiable metrics, especially for current patents that are not not licensed.Due to our unique IP licensing model that uses an enhanced Creative Commons 4.0 ShareAlike (CC4.0 ShareAlike) agreement, we can help patent owners around the world improve the value of their intellectual property assets, especially for those who failed to fire them before. I’m so excited about this partnership that for Therapoid users who also sign up for IPwe, they’ll win a free prize of ScienceCoins!”

In addition, IPwe will encourage researchers and students seeking academic, government and professional positions to freely join Therapoid. Additionally, IPwe’s partnership with Therapoid will provide another way for IPwe to drive innovation by providing the global Therapoid scientific community with a resource to identify which of their patents would best benefit businesses, governments, institutions academics and society in general.

Similarly, Open Therapeutics, through its partnership with the IPwe referral program, will encourage its community members and IP providers to join and create IPwe Smart Pools as Founders by providing the license right to SmartPools. This partnership will enable the Therapoid community to advance and deploy patent-based technologies through the assistance of IPwe Smart Pools.

As pioneers in decentralized science (DeSci), artificial intelligence, blockchain, non-fungible tokens (NFT), open access and open science, Open Therapeutics and IPwe are well positioned to drive convergence of these related technologies and methodologies. Both companies can accelerate an innovative patent licensing model through this combination while achieving positive social outcomes.

About Open Therapeutics

The Company provides the scientific community with the Therapoid™ platform free of charge; a collaborative, open-access science ecosystem that puts scientists and students at the center of research to positively impact human, animal, plant, and global environmental health. Therapoid provides free intellectual property (IP), copyright, grants, free equipment, discussion forums, manuscript review tool, knowledge content center, career and academic opportunities, ScienceCoins cryptocurrency prices and non-fungible tokens (NFTs). All knowledge is provided free of charge under a fully modified Creative Commons 4.0 ShareAlike (CC4.0 ShareAlike) license. Using the Polygon 2 layer on the Ethereum blockchain has provided the company with the opportunity to lead the development of DeSci dApps and develop Therapoid as a decentralized autonomous organization (DAO). Building the world’s largest think tank, members who share openly can be seen by job and student recruiters for career, job and gig opportunities. Therapoid may be especially beneficial for people living in economically developing regions of Africa, Asia, and Latin America.

Media Contact:
Jason E. Barkeloo, Founder/President
Open therapy
https://Therapoid.net
+1.513.252.2901
[email protected]
Twitter: https://twitter.com/OpenTherapeutic
LinkedIn: https://www.linkedin.com/company/10851290
Telegram: https://t.me/Therapoid
Box 30085
Cincinnati, Ohio 45230
UNITED STATES

About IPwe

Founded in 2018, IPwe is a global platform leveraging the power of artificial intelligence, predictive analytics and blockchain technology around the intelligent management of intangible assets. IPwe expands traditional IP markets by increasing transparency with clear, verifiable metrics to reduce costs and improve value and returns. With IPwe, everyone from startups to large enterprises, from business and financial executives to intellectual property experts, can collaborate at the business, technical, legal or financial level to improve efficiency, value, opportunity and innovation to better manage their intangible assets.

press contact
Mia Mixan
Marketing Director
[email protected]
https://ipwe.com

This press release was published on openPR.

Comments are closed.